Neurocrine Biosciences
Price & Volume
Stats
See more52W Range | $122.13-$181.18 |
Market Cap | $17.8B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $3.1B |
Revenue Growth (YoY) | 42.2% |
Gross Profit (12 Mos) | $1.9B |
Diluted EPS | $6.50 |
News
See moreYahoo Finance • 5 days ago
Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2026 Financial Results
Yahoo Finance • 16 days ago
Neurocrine Biosciences (NBIX): High Growth NASDAQ Stocks to Buy Now
Yahoo Finance • 20 days ago
Best Value Stocks to Buy for June 24th
Yahoo Finance • 25 days ago
Weekly Buzz: SPRO, ABBV Get FDA Nod, NMRA Halts KOASTAL; ENGN Cuts Jobs; BIIB Acquires RayThera
About
CEO | Mr. Kyle W. Gano Ph.D. |
Address | 6027 Edgewood Bend Court, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 2,000 |